A Phase I/II Study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metasteses

Publication Date

6-1-2024

Presented At:

American Society of Clinical Oncology (ASCO) Annual Meeting

This document is currently not available here.

Share

COinS